PCC Canada

WHAT TO EXPECT

Advancing Risk Management Models

• Examine new models for managing compliance risk for patient engagement
• Preparation and training for internal audits — Understand internal business ethics and compliance
• Managing risk with third party vendors 
• Discuss industry trends in automating compliance monitoring activities to address compliance risk

Understand How Evolving Regulatory Guidance and Trends Impact Your Compliance Program

• Review of IMC codes and updates, Lama Abi Khaled, Executive Director, Ethics, Legal & Regulatory, Innovative Medicines Canada
• Health Canada Updates and Q&A, Alain G. Musende, PhD, Manager, Therapeutic Effectiveness and Policy Bureau, Health Canada [invited]
• Q&A Session with Patrick Massad, Commissioner, Pharmaceutical Advertising Advisory Board (PAAB)
• DOJ Guidance on Ensuring Effective Compliance Programs: Latest Updates and Recent Development, Nicholas Connor, Senior Counsel, Government Investigations & Litigation, Johnson & Johnson

Examine Best Practices in Data Privacy, IP Law and Competition and Employment Law

Dedicated Content Track for In-house Legal Counsel addressing:

• The risks associated with data breaches and how to manage them
• Data privacy with third-party suppliers
• Complying with new data privacy regulations announced in Canada November 2018
• Best practices in IP Law —
  Copyright, Trademark and Patent
• Ensuring compliance with CASL
• Competition and Employment Law —
  Ethical approaches and pitfalls to avoid